Skip to main content
. 2017 Oct 26;8(58):97811–97821. doi: 10.18632/oncotarget.22083

Table 1. Summary of the 74 RCC patients involved in this study.

Age
 Mean ± SD, year 56.22 ± 13.32
 <60 42 56.8%
 ≥60 32 43.2%
Gender
 Male 47 63.5%
 Female 27 39.5%
Tumor size
 ≤4 42 56.8%
 >4 32 43.2%
Histology
 Clear cell carcinoma 61 82.4%
 Others 13 17.6%
Histological grade
 I 15 20.3%
 II 47 63.5%
 III 9 12.2%
 IV 3 4.0%
Tumor stage
 T1 64 86.5%
 T2 6 8.1%
 T3 4 5.4%
Survival
 Mean ± SD, month 60.73 ± 18.27
 No 13 17.6%
 Yes 61 82.4%
CAPN2 expression
 Low 50 67.6%
 High 24 32.4%

SD, standard deviation.